|
|
 |
| Àâòîðèçàöèÿ |
|
|
|
| Ïîèñê ïî óêàçàòåëÿì |
|
|
|
|
|
|
|
 |
|
|
|
| Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.) — Handbook of Stem Cells (vol. 1) Embryonic Stem Cells |
|
|
|
| Ïðåäìåòíûé óêàçàòåëü |
Graft-versws-host disease 2: 739
Graft-versws-host disease in immune reconstitution by HS cell implant 2: 751—752
Graft-versws-host disease, hematopoietic stem cell transplantation 2: 686—687
Graft-versws-host disease, prophylaxis 2: 740 2:
Granulocyte macrophage-colony stimulating factor 2: 364—365
Granulocyte macrophage-colony stimulating factor in hematopoietic stem cell mobilization 2: 687
Granulocyte-colony stimulating factor 2: 599
Granulocyte-colony stimulating factor in hematopoietic stem cell mobilization 2: 687
Granulocyte-monocyte-restricted progenitors 2: 355 2: 2:
Granulosa cell specification 1: 349—350
Green fluorescent protein 1: 575 2: 2:
Growth plate cartilage 1: 288 1:
Growth-factor receptor-bound protein 1: 30 1:
Gsh—1 gene 1: 584
Guided homologous recombination 2: 793
Hair 2: 245
Hair follicle stem cells 2: 5—6 2: 2: 2:
Hair follicle stem cells, bulge cells and 2: 6 2: 2:
Hair follicle stem cells, differentiation 2: 65—66
Hair follicle stem cells, distribution 2: 250
Hair follicle stem cells, interfollicular epidermal stem cells and 2: 66—67
Hair follicle stem cells, self-renewal 2: 65—66
Hair follicle stem cells, stem cell niche 2: 65—67
Hair follicle stem cells, theoretical models 2: 260—262
Hair, mouse biology 2: 257—258 2:
Hedgehog in Drosophila cell fate signaling 2: 62
Hedgehog, yolk sac development 2: 159—160
Hemangioblasts, characteristics 2: 387
Hemangioblasts, development 1: 94
Hemangioblasts, evidence of 1: 93—94 1:
Hemangioblasts, model of as hematopoietic emergence 1: 96
Hemangioblasts, origin 2: 593
Hemangioblasts, specification 2: 387—391
Hematopoiesis in embryoid bodies 1: 280
Hematopoiesis in mesoderm development 1: 275—276
Hematopoiesis in zebra fish 2: 677—678
Hematopoiesis, aging effects 2: 337—338
Hematopoiesis, current understanding 2: 159 2: 2:
Hematopoiesis, early development 1: 93—95 1: 2: 2: 2: 2: 2:
Hematopoiesis, early development in aorta-gonad-mesonephros region 2: 162—166
Hematopoiesis, early development, bone marrow formation 2: 167
Hematopoiesis, early development, chronology 2: 160t
Hematopoiesis, early development, hematopoietic clusters 2: 162—163
Hematopoiesis, early development, liver development 2: 166—167
Hematopoiesis, early development, spleen ontogeny 2: 167
Hematopoiesis, early development, yolk sac development 2: 159—162 2:
Hematopoiesis, germ line stem cell niches in 2: 64—65
Hematopoiesis, hierarchical model 2: 657
Hematopoiesis, histone role in 2: 108
Hematopoiesis, mesenchymal stem cells in 2: 300—301
Hematopoiesis, multilineage priming in 2: 85—87 2:
Hematopoiesis, osteoclast role in 1: 295
Hematopoiesis, postnatal 2: 596
Hematopoiesis, progenitor cells 1: 323 1:
Hematopoiesis, therapeutic use of processed lipoaspirate cells 2: 439
Hematopoiesis, vascular endothelial growth factor in 2: 378 2:
Hematopoietic progenitor cells 2: 361 2: 2:
Hematopoietic progenitor cells in neoangiogenesis 2: 378
Hematopoietic progenitor cells, clinical trials 2: 619—622 2:
Hematopoietic progenitor cells, definition 2: 22—23
Hematopoietic progenitor cells, ex vivo expansion 2: 74 2: 2:
Hematopoietic progenitor cells, fetal development 2: 365—366
Hematopoietic progenitor cells, gene expression profile 2: 361—362
Hematopoietic progenitor cells, genome editing 2: 797—798
Hematopoietic progenitor cells, growth factors 2: 621
Hematopoietic progenitor cells, isolation and characterization 2: 615 2:
Hematopoietic stem cells from umbilical cord blood 2: 181—185
Hematopoietic stem cells in autoimmune disease treatment 2: 754
Hematopoietic stem cells in gastrointestinal repopulation 2: 528—530
Hematopoietic stem cells in immune system reconstitution 2: 745 2:
Hematopoietic stem cells in leukemogenesis 2: 315—316
Hematopoietic stem cells in T cell formation 1: 677 2:
Hematopoietic stem cells, adult 2: 594
Hematopoietic stem cells, adult in vascular regeneration 2: 461
Hematopoietic stem cells, adult, mobilization and homing 2: 593—601
Hematopoietic stem cells, adult, origins 2: 84
Hematopoietic stem cells, aging effects 2: 337—343
Hematopoietic stem cells, biologic significance 1: 279 2:
Hematopoietic stem cells, cardiac implantation 2: 714—715 2:
Hematopoietic stem cells, cell cycle control 2: 73 2:
Hematopoietic stem cells, cell cycle control, aging effects 2: 338
Hematopoietic stem cells, cell fate decisions 2: 26—28 2:
Hematopoietic stem cells, cell fate options 2: 115 2:
Hematopoietic stem cells, cell markers 2: 22 2: 2: 2: 2: 2: 2: 2:
Hematopoietic stem cells, chimerism-induced immune tolerance 1: 670 1: 1:
Hematopoietic stem cells, circulating populations 2: 685—687
Hematopoietic stem cells, clinical significance 1: 521 2: 2: 2: 2:
Hematopoietic stem cells, clonal analysis 2: 651—658
Hematopoietic stem cells, current understanding 2: 159 2: 2:
Hematopoietic stem cells, differentiation 2: 27 2: 2: 2:
Hematopoietic stem cells, differentiation, aging effects 2: 340—341
Hematopoietic stem cells, early research 2: 1 2: 2:
Hematopoietic stem cells, embryoid body-derived 1: 280 1: 2:
Hematopoietic stem cells, engraftment capacity 1: 522—523 2:
Hematopoietic stem cells, ES cell-derived 1: 279 1: 1:
Hematopoietic stem cells, evidence of plasticity 2: 14—15 2:
Hematopoietic stem cells, ex vivo expansion 2: 622—623
Hematopoietic stem cells, expansion cultures 2: 663 2:
Hematopoietic stem cells, functional assays 1: 521—522
Hematopoietic stem cells, functional characteristics 2: 13 2: 2: 2: 2:
Hematopoietic stem cells, gene expression ground state 2: 27
Hematopoietic stem cells, gene expression profile 2: 361—362
Hematopoietic stem cells, gene modification to improve engraftment 1: 280—281
Hematopoietic stem cells, genome editing 2: 797—798
Hematopoietic stem cells, genomic research 2: 23 2:
Hematopoietic stem cells, genomic research, molecular parts list 2: 26
Hematopoietic stem cells, genomic research, purity of populations for 2: 23—25
Hematopoietic stem cells, global gene expression profile 2: 89—90
Hematopoietic stem cells, heterogeneity 2: 16
Hematopoietic stem cells, homing capacity 2: 184—185 2:
Hematopoietic stem cells, homing capacity, aging effects 2: 339
Hematopoietic stem cells, homing capacity, defined 2: 596
Hematopoietic stem cells, homing capacity, mobilization processes and 2: 596—599
Hematopoietic stem cells, human, clinical applications 1: 521
Hematopoietic stem cells, human, future research 1: 526—527
Hematopoietic stem cells, human, progenitor cells 1: 521—524
Hematopoietic stem cells, human, progression from ES cells 1: 524—526
Hematopoietic stem cells, immunophenotyping 2: 115
Hematopoietic stem cells, in neoangiogenesis 2: 378
Hematopoietic stem cells, inducing ES cell differentiation to 1: 317—318
Hematopoietic stem cells, insulin-producing cells derived from 2: 734
Hematopoietic stem cells, isolation and characterization techniques 2: 323 2: 2:
Hematopoietic stem cells, isolation and characterization techniques, dye efflux studies 2: 324—325
Hematopoietic stem cells, isolation and characterization techniques, surface markers 2: 323—324
Hematopoietic stem cells, isolation and maintenance 1: 501 1:
Hematopoietic stem cells, life span 2: 22
Hematopoietic stem cells, lineage commitment 2: 313—314
Hematopoietic stem cells, lineage map 2: 25
Hematopoietic stem cells, long-term/short-term 2: 355 2:
Hematopoietic stem cells, migration streams 2: 164f 2: 2:
Hematopoietic stem cells, migration streams, homing capacity 2: 339
Hematopoietic stem cells, mobilization 2: 687—689
Hematopoietic stem cells, mobilization, experimental techniques 2: 595—596
Hematopoietic stem cells, mobilization, homing process and 2: 596—599
Hematopoietic stem cells, mobilization, proangiogenic recruitment 2: 377—383
Hematopoietic stem cells, mobilization, strategies for improving 2: 600—601
Hematopoietic stem cells, mouse 1: 521 1:
Hematopoietic stem cells, multilineage priming 2: 85—87 2:
Hematopoietic stem cells, muscle stem cell origins in 2: 399
Hematopoietic stem cells, muscle-derived 2: 405—412
Hematopoietic stem cells, myeloid gene expression 2: 87
Hematopoietic stem cells, myogenic potential 2: 723
Hematopoietic stem cells, origins 1: 275—276 2: 2:
Hematopoietic stem cells, phenotypes 2: 323—325 2:
Hematopoietic stem cells, primitive and precursor cells 1: 521—524 1:
Hematopoietic stem cells, prospective definition 2: 23—25
Hematopoietic stem cells, regulation of stem cell products and research 1: 776—777 2:
Hematopoietic stem cells, replicative potential 2: 132—133
Hematopoietic stem cells, retrospective definition 2: 22—23
Hematopoietic stem cells, self-renewal 2: 27—28 2: 2: 2: 2:
| Hematopoietic stem cells, self-renewal, aging effects 2: 338 2:
Hematopoietic stem cells, self-renewal, regulation 2: 183—184
Hematopoietic stem cells, slide population cells as 2: 332
Hematopoietic stem cells, sources 2: 13
Hematopoietic stem cells, spontaneous fusion 1: 115 2:
Hematopoietic stem cells, stem cell niches 2: 38 2: 2:
Hematopoietic stem cells, stochastic regulation 2: 26
Hematopoietic stem cells, telomerase function 2: 127 2:
Hematopoietic stem cells, tissue engineering applications 2: 783—784
Hematopoietic stem cells, transcription regulation 2: 309—316
Hematopoietic stem cells, transdifferentiation 2: 84 2:
Hematopoietic stem cells, transdifferentiation into insulin-producing cells 2: 734
Hematopoietic stem cells, transplantation 2: 685—689
Hematopoietic stem cells, tumor treatment 2: 739—742
Hematopoietic stem cells, yolk sac development 2: 161—162
Hematopoietic stem cells, zebra fish 2: 677 2:
Hepatic stem cells 2: 486 2: 2:
Hepatic stem cells, activation 2: 497—509
Hepatic stem cells, activation, cellular events 2: 500—501 2:
Hepatic stem cells, activation, extracellular matrix 2: 501
Hepatic stem cells, activation, molecular factors 2: 503—506 2:
Hepatic stem cells, differentiation 2: 498 2:
Hepatic stem cells, hepatocyte replacement 2: 497—41—98
Hepatic stem cells, localization 2: 498—499 2:
Hepatoblasts 1: 360
Hepatoblasts, transplantation 2: 487
Hepatocyte growth factor 2: 715
Hepatocytes, amniotic fluid progenitor cell-derived 2: 176—178
Hepatocytes, culturing 1: 359—360 1:
Hepatocytes, differentiation 2: 500—501 2:
Hepatocytes, ES cell differentiation 1: 362—367 1:
Hepatocytes, genetic marking 1: 365—366
Hepatocytes, markers in vivo 1: 360—361
Hepatocytes, replacement mechanisms 2: 497—498 2:
Hepatocytes, replacement mechanisms, termination of proliferation 2: 508—509
Hepatocytes, transplantation 1: 359 1: 1:
Hepatocytes, transplantation, cell sources 1: 359—360
Hepatocytes, ultras tructure 1: 361
Hereditary SP-B deficiency 1: 387
Herpes simplex virus thymidine kinase 1: 545 1:
Hes6 protein 2: 199
Heterodimeric transcription factor 1: 91
Hierarchical clustering of microarray data 2: 646
Hierarchical organization of stem cells, hematopoietic 2: 26 2:
Hierarchical organization of stem cells, intestinal 2: 3 2:
High-proliferative potential multipotent colony-forming cells 2: 161 2:
Histocompatibility complexes 1: 664—667 1: 1:
Histone acetyltransferases 1: 69—70 1:
Histone acetyltransferases in early development 2: 106
Histone acetyltransferases in hematopoiesis 2: 108
Histone acetyltransferases, biologic significance 2: 105
Histone acetyltransferases, classification 2: 105—106
Histone acetyltransferases, genomic imprinting and 2: 107
Histone acetyltransferases, knockouts 2: 108—109
Histone acetyltransferases, role in differentiation 2: 107—108
Histone acetyltransferases, structure and function 2: 105
Histone acetyltransferases, substrates 2: 106 2:
Histone deacetylases 1: 68 1:
Histone deacetylases in early development 2: 106
Histone deacetylases in hematopoiesis 2: 108
Histone deacetylases, function 2: 105
Histone deacetylases, knockouts 2: 109
Histone deacetylases, role in differentiation 2: 107—108
Histone deacetylases, X-chromosome inactivation and 2: 106—107
Histone methyltransferases 1: 68 1: 2:
Histone methyltransferases, biologic significance 2: 110
Histone modification 1: 67 1: 1: 2:
Histone modification, epiblast pluripotency and 1: 660
Histone ubiquitylation 2: 110
Hit-and-run method 1: 547
Hitchhiker effect 1: 592—593
HIV 1: 701
HIV-derived transfection vectors 1: 557—560 1: 1:
HNF transcription factors 2: 503—504 2:
Hoescht-33342 2: 25 2: 2: 2:
Hoescht-33342, applications 2: 329
Hoescht-33342, DNA binding action 2: 329 2: 2:
Hoescht-33342, slide population cells 2: 329—335
Holoclones 2: 246—247 2:
Homologous recombination of zebra fish ES cells 1: 497—498
Homologous recombination, biomedical significance 1: 551 1:
Homologous recombination, defined 1: 589
Homologous recombination, gene silencing 1: 546
Homologous recombination, gene targeting 1: 546—547
Homologous recombination, HPRT1 gene ablation for 1: 551—553 1:
Homologous recombination, in human ES cells 1: 551—555
Homologous recombination, Oct4 knockin 1: 553—554 1:
Hop gene 1: 174—175
Hox genes in gastrointestinal development 1: 372—373
Hox genes in hematopoietic stem cell self-renewal 2: 27 2: 2:
Hox genes in intestinal cell regulation 2: 533—534
Hox genes in neural crest cell development 1: 222—225 2:
Hox genes in skeletogenesis 1: 287
Hox genes in thymus and parathyroid development 1: 393—394 1:
Hox genes in thymus development 2: 556—557
Hox genes to enhance hematopoietic engraftment 1: 280—281
Hox genes, genetic pathway studies 1: 584
HPRT1 gene ablation 1: 551—553 1:
Human leukocyte antigen 1: 664—667 1: 1: 2:
Human leukocyte antigen, natural killer cells and 1: 667—668
Human leukocyte antigen, transplant donor matching 1: 668—669
Huntington’s disease 1: 245—246 2: 2:
Hyaluronic acid 2: 598
Hybrid cells see “Cell fusion”
Hybrid vigor 2: 154
Hydra, anatomy 2: 47 2:
Hydra, axial patterning 2: 51—52 2:
Hydra, cell biology 2: 47 2:
Hydra, cell biology, epithelial cells 2: 47 2: 2:
Hydra, cell biology, interstitial cells 2: 52—55
Hydra, evolutionary context 2: 55—56
Hydra, tissue dynamics 2: 47
Hypoblast cells 1: 150
Hypomorphic allele mutations 1: 599
Hypoxanthine guanine phosphoribosyl transferase gene 1: 546
Hypoxanthine-aminopterin-thymidine selection method 2: 153—154
Hypoxia in cardiovascular system development 1: 92—93
Hypoxia in embryogenesis 1: 91—93 1:
Hypoxia in hemangioblast formation 1: 94
Hypoxia in hematopoietic development 1: 95
Hypoxia in placental development 1: 95—96
Hypoxia inducible factor in embryogenesis 1: 91 1:
Hypoxia inducible factor in trophoblast stem cell differentiation 1: 96
Hypoxia inducible factor, overexpression 1: 93
Hypoxia inducible factor, target genes 1: 91—92
Hypoxia inducible factor, translation regulation 1: 92
Hypoxia, neurological disorders caused by 1: 696
Hypoxia, regulation 1: 92 1:
Ideal discriminator analysis 2: 646
Immune function, adaptive 2: 745
Immune function, age-related changes 2: 745 2:
Immune function, B cell formation and function 2: 748—749
Immune function, dendritic cells in 2: 360
Immune function, genetic engineering of 1: 670—671
Immune function, graft rejection pathways 1: 664 1: 1:
Immune function, human ES cell immunogenicity 1: 663—668
Immune function, human ES cell immunogenicity, implications for transplantation 1: 663 1:
Immune function, immune-privileged graft sites 1: 668
Immune function, innate 2: 745
Immune function, major histocompatibility complex 1: 664—667 1: 1:
Immune function, maternal, during implantation 1: 151—152
Immune function, minor histocompatibility complex 1: 667
Immune function, obstacles to transplantation 1: 675
Immune function, pancreatic  -cell transplantation and 1: 727
Immune function, phylogeny 2: 745
Immune function, reconstitution strategies 2: 745 2:
Immune function, T cell formation and function 2: 745—748
Immune function, tolerance induction by hematopoietic chimerism 1: 670 1: 1:
Immune function, tolerance induction by manipulation of thymocytes 1: 675—682
Immunoglobulins 2: 748 2:
|
|
|
| Ðåêëàìà |
|
|
|
|
|
Î ïðîåêòå